Find every episode below.
How To Listen
There are many ways to listen to our episodes.
You can stream them. You can download them.
You can put them on your phone or tablet. It’s up to you.
PLEASE NOTE: IF YOU WANT TO ACCESS ALL OF THE PREMIUM CONTENT
Or just click on an episode below and stream it.
Our guest on this episode is American investor David Waldron, author of “Build Wealth With Common Stocks”, a great, new introduction to value investing.
Selling HAW. GME lawsuit. Changes to disclosure law. Stock of the week. Return on Equity as a metric. Greater portfolio allocation for higher QAV scores. Trendline buffers. Manually entered scores. BOQ / ME merger. MXI qualified audit. MQG Capital Notes 5 raise. Selling “overvalued” stocks.
The Kohler Effect. Broker Speak. ETF surge. Rudi on Value. The “Buffett indicator”. Stock of the week – BOQ. On market share buyback facilities. GDG and Pooled Development Fund (PDF). Reporting season patterns. MSV impairment announcement. Last Period Analysed column. KRM care and maintenance. VUK sell line.
This is the audio from our 4th Zoom call recorded 9 Feb 2021.
On this episode: GME update; BNPL stocks to be regulated in the UK; Roger Montgomery says there’s no ASX bubble; Stock Doctor commodity pricing; NCK is TK’s Stock of the Week; our portfolio EOM report; VUK cashflow; investing based on commodity prices; if TK would use options; what TK would do if there were two stocks with with similar scores; and is a buy/sell activated if price crosses over the line intra-month?
Hedge funds v Reddit. Ray Dalio on Bitcoin. Tony’s journal entries. Portfolio update. Regression testing Tobias Carlisle. TK’s “war stories” of the ’99/’00 bubble. CCV 3PTL Sentiment. KRM coming out the naughty corner. SD cashflow. Index Mundi data dates.
This week: ASX lower on fears of US bubble. Howard Marks’ capitulation. Ray Dalio’s thoughts on a coming US civil war. Using Gross Revenue Growth per Share to value “growth” stocks. Stock of the week – KRM. Using a logarithmic price scale. Tony’s thoughts on the Blue-Chippers in the ASX. Determining ‘Consistently Increasing Equity’. Defining ‘recent positive upturn’. Reasons to sell. NTD and the AUD. Waiting for reporting season. How to apportion additional funds. Sell lines for GGE, NHC, ESS.
data-episode-id="780508" data-theme="dark" data-visual="true"...
In our first episode of 2021, we review our portfolio’s CY20 performance; margin loan rates; What TK does on a daily/weekly basis for managing his portfolio; relative QAV performance of large vs mid vs small cap companies; the ‘minimum’ amount of stock someone just getting started should buy; fudging ECX and VUK; whether or not we should rebalance every so often; Tony’s views on CSL; the recent drop in the prices of some gold miners; understanding the formula in column BK of the master checklist; why companies can have a quality score of >100%; and Stock Doctor problems regarding reporting of director holdings.